Christoph Steiger

Learn More
Today’s reconfigurable hardware devices have huge densities and are partially reconfigurable, allowing for the configuration and execution of hardware tasks in a true multitasking manner. This makes reconfigurable platforms an ideal target for many modern embedded systems that combine high computation demands with dynamic task sets. A rather new line of(More)
This paper deals with online scheduling of tasks to partially reconfigurable devices. Such devices are able to execute several tasks in parallel. All tasks share the reconfigurable surface as a single resource which leads to highly dynamic allocation situations. To manage such devices at runtime, we propose a reconfigurable operating system that splits into(More)
Partially reconfigurable devices allow to configure and execute tasks in a true multitasking manner. The main characteristics of mapping tasks to such devices is the strong nexus between scheduling and placement. In this paper, we formulate a new online real-time scheduling problem and present two heuristics, the horizon and the stuffing technique, to(More)
Partial reconfiguration allows for mapping and executing several tasks on an FPGA during runtime. Multitasking on FPGAs raises a number of questions on the management of the reconfigurable resource which leads to the concept of a reconfigurable operating system. A major aspect of such an operating system is task placement. Online placement methods are(More)
Therapeutic gases enriched into perfusion solutions have been effectively used for the improvement of organ transplant quality. At present, the enrichment of perfusion solutions with gases requires complex machinery/containers and handling precautions. Alternatively, the gas is generated within the perfusion solution by supplemented carbonylated transition(More)
Carbon monoxide (CO) is an endogenous signal transmitter involved in numerous physiological processes including the gastrointestinal (GI) homeostasis. CO has been recognized as potential new therapeutic agent for motility related and inflammatory disorders of the GI tract. A therapeutic use, however, is challenged by inappropriate drug delivery modes. Here(More)
Deploying the therapeutic potential of carbon monoxide (CO) in various gastrointestinal diseases is challenged by inappropriate oral delivery modes. It is for this challenge, that we developed an easy to use tablet referred to as oral carbon monoxide release system (OCORS) providing precise, controlled, tunable and targeted CO delivery for the treatment of(More)
Counterfeit drugs are a major threat to public health. Current efforts focus on serialization of the secondary packaging which do not allow to trace the individual unit. As a proof of concept, we intended to mark each tablet for its unambiguous recognition. Spiking monodisperse PEGs into tablet coating solutions at concentrations as low as 3 ppm was(More)
The heme oxygenase (HO)/carbon monoxide (CO) system is a physiological feedback loop orchestrating various cell-protective effects in response to cellular stress. The therapeutic use of CO is impeded by safety challenges as a result of high CO-Hemoglobin formation following non-targeted, systemic administration jeopardizing successful CO therapies as of(More)
  • 1